Avaliação de leguminosas para cobertura do solo.

bitstream/CNPAB-2010/27249/1/doc055.pd

Evaluation of genetic divergence among clones of conilon coffee after scheduled cycle pruning.

Coffea canephora genotypes from the breeding program of Instituto Capixaba de Pesquisa e Extensão Rural were evaluated, and genetic diversity was estimated with the aim of future improvement strategies. From an initial group of 55 genotypes, 18 from the region of Castelo, ES, were selected, and three clones of the cultivars ?Vitória? and ?robusta tropical.? Upon completion of the scheduled cycle pruning, 17 morphoagronomic traits were measured in the 22 genotypes selected. The principal components method was used to evaluate the contributions relative to the traits. The genetic dissimilarity matrix was obtained through Mahalanobis generalized distance, and genotypes were grouped using the hierarchical method based on the mean of the distances. The most promising clones of Avaliação Castelo were AC02, AC03, AC12, AC13, AC22, AC24, AC26, AC27, AC28, AC29, AC30, AC35, AC36, AC37, AC39, AC40, AC43, and AC46. These methods detected high genetic variability, grouping, by similarity, the genotypes in five groups. The trait that contributed the least to genetic divergence was the number of leaves in plagiotropic branches; however, this was not eliminated, because discarding it altered the groups. There are superior genotypes with potential for use in the next stages of the breeding program, aimed at both the composition of clonal variety and hybridizations201

Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients

Made available in DSpace on 2015-09-21T17:25:43Z (GMT). No. of bitstreams: 2 license.txt: 1914 bytes, checksum: 7d48279ffeed55da8dfe2f8e81f3b81f (MD5) ro_pinheiro_etal_IOC_2013.pdf: 615557 bytes, checksum: beca6bdc51ba9bec799e42f2a2f30dcf (MD5) Previous issue date: 2013Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Centro de Referência Hélio Fraga. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Laboratório de Doença de Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Hospital Municipal Raphael de Paula Souza. Unidade de Saúde. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Centro de Referência Hélio Fraga. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil / National Institutes of Health, NIH. Laboratory of Clinical Infectious Diseases, LCID/NIAID. Immunopathogenesis Section. Bethesda, WA, USA.Previous studies have demonstrated that cells from both multi-drugresistant tuberculosis (MDR-TB) and non-tuberculous mycobacteria (NTM) patients respond poorly to mycobacterial antigens in vitro. In the present study, we compared the in vitro response of cells isolated from sensitive TB (NR-TB)-, MDR-TB- and NTM-infected patients. Analysis of T cell phenotype ex vivo revealed that both MDR-TB and NTM patients present an increased percentage of CD4+CD25+- forkhead box protein 3 (FoxP3)+ and CD4+CD25+CD127- regulatory T (Treg) cells when compared to NR-TB. Increased numbers of Treg cells and interleukin (IL)-10 serum levels were detected in MDR-TB, whereas elevated serum transforming growth factor (TGF)-b was found in the NTM group. Cells of MDR-TB patients stimulated with early secretory antigenic target (ESAT)-6, but not purified protein derivative (PPD), showed a lower frequency of CD4+/interferon (IFN)-g+ T cells and enhanced CD4+CD25+FoxP3+, CD4+CD25+CD127- and CD4+CD25+IL-10+ T cell population. In addition, increased IL-10 secretion was observed in cultured MDR-TB cells following ESAT-6 stimulation, but not in NR-TB or NTM patients. In vitro blockade of IL-10 or IL-10Ra decreased the CD4+CD25+FoxP3+ frequencies induced by ESAT-6 in MDRTB, suggesting a role of IL-10 on impaired IFN-g responses seen in MDR-TB. Depletion of CD4+CD25+ T lymphocytes restored the capacity of MDR-TB T cells to respond to ESAT-6 in vitro, which suggests a potential role for Treg/T regulatory 1 cells in the pathogenesis of MDR-TB. Together, our results indicate that although the similarities in chronicity, NTM- and MDRTB- impaired antigenic responses involve different mechanisms

Plantas de cobertura de solo como hospedeiras alternativas de Colletotrichum guaranicola Cover crops as intermediate hosts to Colletotrichum guaranicola

As plantas de cobertura de solo usadas para suprimir o crescimento de plantas daninhas podem hospedar fungos fitopatogênicos. Para testar essa hipótese, elaborou-se este trabalho com o objetivo de avaliar o comportamento de nove espécies de plantas como possíveis hospedeiras do fungo Colletotrichum guaranicola. O experimento foi conduzido em casa de vegetação sob delineamento inteiramente casualizado, com quatro repetições. Cada vaso com três plantas da mesma espécie representou uma unidade experimental. As espécies que constituíram os tratamentos foram: Arachis pintoi, Calopogonium mucunoides, Chamaecrista rotundifolia, Crotalaria striata, Desmodium ovalifolium, Flemingia congesta, Mucuna aterrima, Pueraria phaseoloides e Tephrosia candida. Quarenta dias após a semeadura, as plantas foram inoculadas com suspensão de esporos de C. guaranicola na concentração de 10(5) conídios mL¹, enquanto as plantas testemunhas receberam somente água. As plantas foram mantidas em câmara úmida por 48 horas. Diariamente, foram feitas observações por 15 dias após a inoculação, para visualizar sintomas da doença. As espécies que não apresentaram sintomas de C. guaranicola foram Arachis pintoi, Chamaecrista rotundifolia, Desmodium ovalifolium, Flemingia congesta e Tephrosia candida, e as que manifestaram sintomas após a inoculação foram Calopogonium mucunoides, Crotalaria striata, Mucuna aterrima e Pueraria phaseoloides, que podem ser fontes de inóculo do patógeno da antracnose para o guaranazeiro.<br>Cover crops used to suppress weed growth can be intermediate hosts to phytopathogenic fungi. To test this hypothesis, nine species of cover crops were evaluated as hosts to Colletotrichum guaranicola. The experiment was arranged in a randomized design, with four replicates, and conducted under greenhouse conditions. Each vase with three plants of one species constituted one plot. The species treated were: Arachis pintoi, Calopogonium mucunoides, Chamaecrista rotundifolia, Crotalaria striata, Desmodium ovalifolium, Flemingia congesta, Mucuna aterrima, Pueraria phaseoloides and Tephrosia candida. Forty days after sowing, the plants were inoculated with spores of C. guaranicola at a concentration of105 conidia/mL, while the control plants received only water. The plants were then kept in a humid chamber for 48 hours. Daily observations were made to search for symptoms during 15 days after inoculation. The species that did not present symptoms of C. guaranicola were Arachis pintoi, Chamaecrista rotundifolia, Desmodium ovalifolium, Flemingia congesta and Tephrosia candida and those that did were Calopogonium mucunoides, Crotalaria striata, Mucuna aterrima and Pueraria phaseoloides, being a potential source of inoculation of the pathogen anthracnose for the guarana plant

Clinical standards for drug-susceptible pulmonary TB.

The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB). A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants. Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB. These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB

Clinical standards for drug-susceptible pulmonary TB.

The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB). A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants. Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB. These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB

Clinical standards for drug-susceptible pulmonary TB.

BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).METHODS: A panel of 54 global experts in the field of TB care, public health, microbiology, and pharmacology were identified; 46 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all 46 participants.RESULTS: Seven clinical standards were defined: Standard 1, all patients (adult or child) who have symptoms and signs compatible with PTB should undergo investigations to reach a diagnosis; Standard 2, adequate bacteriological tests should be conducted to exclude drug-resistant TB; Standard 3, an appropriate regimen recommended by WHO and national guidelines for the treatment of PTB should be identified; Standard 4, health education and counselling should be provided for each patient starting treatment; Standard 5, treatment monitoring should be conducted to assess adherence, follow patient progress, identify and manage adverse events, and detect development of resistance; Standard 6, a recommended series of patient examinations should be performed at the end of treatment; Standard 7, necessary public health actions should be conducted for each patient. We also identified priorities for future research into PTB.CONCLUSION: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB

Perennial herbaceous legumes as live soil mulches and their effects on C, N and P of the microbial biomass Leguminosas herbáceas perenes como cobertura viva do solo e seu efeito no C, N e P da biomassa microbiana

The use of living mulch with legumes is increasing but the impact of this management technique on the soil microbial pool is not well known. In this work, the effect of different live mulches was evaluated in relation to the C, N and P pools of the microbial biomass, in a Typic Alfisol of Seropédica, RJ, Brazil. The field experiment was divided in two parts: the first, consisted of treatments set in a 2 x 2 x 4 factorial combination of the following factors: live mulch species (Arachis pintoi and Macroptilium atropurpureum), vegetation management after cutting (leaving residue as a mulch or residue remotion from the plots) and four soil depths. The second part had treatments set in a 4 x 2 x 2 factorial combination of the following factors: absence of live mulch, A. pintoi, Pueraria phaseoloides, and M. atropurpureum, P levels (0 and 88 kg ha-1) and vegetation management after cutting. Variation of microbial C was not observed in relation to soil depth. However, the amount of microbial P and N, water soluble C, available C, and mineralizable C decreased with soil depth. Among the tested legumes, Arachis pintoi promoted an increase of microbial C and available C content of the soil, when compared to the other legume species (Pueraria phaseoloides and Macroptilium atropurpureum). Keeping the shoot as a mulch promoted an increase on soil content of microbial C and N, total organic C and N, and organic C fractions, indicating the importance of this practice to improve soil fertility.<br>A adoção de práticas de cobertura do solo com leguminosas tem aumentado. Porém, o impacto desta prática sobre o compartimento microbiano ainda não é bem conhecido. Para avaliar o efeito de diferentes leguminosas, sobre o C, N e P da biomassa microbiana, coletaram-se amostras de Argissolo oriundas de um experimento sob condições de campo em Seropédica-RJ. O experimento foi subdividido em dois ensaios. No primeiro, os tratamentos corresponderam à combinação de três fatores: espécie de cobertura viva (Arachis pintoi e Macroptilium atropurpurem), manutenção em cobertura ou remoção dos resíduos após o corte e profundidade de coleta do solo. No segundo ensaio, os tratamentos corresponderam à combinação de três fatores: ausência de cobertura viva, A. pintoi, Pueraria phaseoloides e M. atropurpureum, doses de P (0 e 88 kg ha-1) e manejo dos resíduos da parte aérea das plantas. Não houve variação do C microbiano com a profundidade do solo. Porém, para o P e N microbianos, C orgânico do solo, C solúvel em água, disponível e mineralizável, o aumento da profundidade proporcionou diminuição destas características. As leguminosas usadas influenciaram de maneira diferenciada as variáveis analisadas. O A. pintoi promoveu elevação nos teores de C microbiano e disponível, comparativamente as demais espécies utilizadas (P. phaseoloides e M. atropurpureum). A manutenção dos resíduos das leguminosas após cada corte promoveu aumentos nos teores de C e N microbianos, C orgânico e N total e frações de C orgânico do solo enfatizando a importância de utilização desta prática para melhorar a fertilidade do solo